Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.
Çelik H, Lindblad KE, Popescu B, Gui G, Goswami M, Valdez J, DeStefano C, Lai C, Thompson J, Ghannam JY, Fantoni G, Biancotto A, Candia J, Cheung F, Sukumar G, Dalgard CL, Smith RH, Larochelle A, Dillon LW, Hourigan CS. Çelik H, et al. Among authors: destefano c. Blood Adv. 2020 Jan 28;4(2):367-379. doi: 10.1182/bloodadvances.2019001124. Blood Adv. 2020. PMID: 31985806 Free PMC article.
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Wong HY, Sung AD, Lindblad KE, Sheela S, Roloff GW, Rizzieri D, Goswami M, Mulé MP, Ramos NR, Tang J, Thompson J, DeStefano CB, Romero K, Dillon LW, Kim DY, Lai C, Hourigan CS. Wong HY, et al. Among authors: destefano cb. Front Oncol. 2019 Jan 15;8:669. doi: 10.3389/fonc.2018.00669. eCollection 2018. Front Oncol. 2019. PMID: 30697529 Free PMC article.
Heterogeneity in refractory acute myeloid leukemia.
Horibata S, Gui G, Lack J, DeStefano CB, Gottesman MM, Hourigan CS. Horibata S, et al. Proc Natl Acad Sci U S A. 2019 May 21;116(21):10494-10503. doi: 10.1073/pnas.1902375116. Epub 2019 May 7. Proc Natl Acad Sci U S A. 2019. PMID: 31064876 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34233281
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis.
Dillon LW, Ghannam J, Nosiri C, Gui G, Goswami M, Calvo KR, Lindblad KE, Oetjen KA, Wilkerson MD, Soltis AR, Sukumar G, Dalgard CL, Thompson J, Valdez J, DeStefano CB, Lai C, Sciambi A, Durruthy-Durruthy R, Llanso A, Gulati S, Wang S, Ooi A, Dagur PK, McCoy JP, Burr P, Li Y, Hourigan CS. Dillon LW, et al. Among authors: destefano cb. Blood Cancer Discov. 2021 Jul;2(4):319-325. doi: 10.1158/2643-3230.BCD-21-0046. Epub 2021 May 25. Blood Cancer Discov. 2021. PMID: 34258102 Free PMC article.
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia.
Goswami M, Gui G, Dillon LW, Lindblad KE, Thompson J, Valdez J, Kim DY, Ghannam JY, Oetjen KA, Destefano CB, Smith DM, Tekleab H, Li Y, Dagur P, Hughes T, Marté JL, Del Rivero J, Klubo-Gwiezdzinksa J, Gulley JL, Calvo KR, Lai C, Hourigan CS. Goswami M, et al. Among authors: destefano cb. J Immunother Cancer. 2022 Jan;10(1):e003392. doi: 10.1136/jitc-2021-003392. J Immunother Cancer. 2022. PMID: 35017151 Free PMC article.
The Evolving AML Genomic Landscape: Therapeutic Implications.
Horibata S, Alyateem G, DeStefano CB, Gottesman MM. Horibata S, et al. Curr Cancer Drug Targets. 2020;20(7):532-544. doi: 10.2174/1568009620666200424150321. Curr Cancer Drug Targets. 2020. PMID: 32329691 Free PMC article. Review.
32 results